compound
CJC-1295 DAC (5mg Vial) Questions Answered
CJC-1295 DAC is a long-acting synthetic analog of growth hormone-releasing hormone (GHRH).
CJC-1295 DAC (5mg Vial)
Week Per-Injection Dose (mcg) Units (per injection) (mL) Weekly Total Weeks 1–2 300 mcg (0.3 mg) 12 units (0.12 mL) 600 mcg/week Weeks 3–4 500 mcg (0.5 mg) 20 units (0.20 mL) 1000 mcg/week Weeks 5–6 750 mcg (0.75 mg) 30 units (0.30 mL) 1500 mcg/week Weeks 7...
CJC-1295 DAC is a long-acting synthetic analog of growth hormone-releasing hormone (GHRH).
Week Per-Injection Dose (mcg) Units (per injection) (mL) Weekly Total Weeks 1–2 300 mcg (0.3 mg) 12 units (0.12 mL) 600 mcg/week Weeks 3–4 500 mcg (0.5 mg) 20 units (0.20 mL) 1000 mcg/week Weeks 5–6 750 mcg (0.75 mg) 30 units (0.30 mL) 1500 mcg/week Weeks 7...
Plan based on an 8–16 week twice-weekly protocol with gradual titration. Peptide Vials (CJC-1295 DAC, 5 mg each): 8 weeks ≈ 3 vials (~10.2 mg total) 12 weeks ≈ 4 vials (~18.2 mg total) 16 weeks ≈ 6 vials (~26.2 mg total) Insulin Syringes (U-100): Per week:...
Practical considerations for consistency and safety. Use new sterile insulin syringes; dispose in a sharps container.